Neşe Devenot participated in a Delphi consensus study to determine reporting guidelines for environmental (or “extra-pharmacological”) factors in psychedelic research settings. Devenot was one of 89 experts from 17 countries who participated in the iterative process. The study produced the Reporting of Setting in Psychedelic Clinical Trials (ReSPCT) guidelines. According to the resulting paper, “Their 30 items represent the first international consensus regarding which specific non-pharmacological elements exert the most important influences on psychedelic drug effects, and thus warrant routine reporting in psychedelic clinical trials.” Devenot is an author on the paper, “An international Delphi consensus for reporting of setting in psychedelic clinical trials,” which was published in Nature Medicine in June 2025.